Alerislife Inc. (NASDAQ:ALR)

Alere Inc. engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products in the United States and internationally. The company’s Professional Diagnostics segment provides an array of diagnostic test products and other in vitro diagnostic tests for the detection of cardiac conditions, pregnancy, infectious diseases, oncology, and drugs of abuse. Its Health Management segment offers programs and services focused on wellness, disease and condition management, productivity enhancement, and informatics. This segment’s health management programs include disease management program, patient self-testing services, obstetrical care services, oncology program, wellness programs, and health management portal. The company’s Consumer Diagnostics segment offers over-the-counter pregnancy and fertility/ovulation test products. This segment also provides over-the-counter drugs of abuse tests for at-home testing; and tests for alcohol abuse, cholesterol monitoring, and colon cancer screening, as well as offers Balance Activ Vaginal Gel for the treatment of bacterial vaginosis without antibiotics. Alere Inc. sells and markets its professional diagnostic products to hospitals, reference laboratories, physicians’ offices, and other point-of-care settings through its sales forces and distribution networks; health management programs to health plans and self-insured employers, pharmaceutical companies, and physicians through channel partners; and consumer drug testing products to consumers and healthcare professionals through retail drug stores, drug wholesalers, groceries, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. on July 15, 2010. Alere Inc. was founded in 2001 and is based in Waltham, Massachusetts..

Web site: http:// http://www.invernessmedical.com

Last updated January 28, 2009